Home › Funds › Opaleye Management Inc. › QTTB
Opaleye Management Inc. position in QTTB
Q32 Bio Inc · Health Care
Opaleye Management Inc. reported holding 931,000 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$11.9M, representing 1.07% of its reported portfolio and ranking #27 among its reported holdings. Opaleye Management Inc. has disclosed QTTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s QTTB position evolved
Opaleye Management Inc. first disclosed a stake in QTTB in Q4 2025 at 213,363 shares (US$708K). The position peaked in Q2 2026 at 931,000 shares, worth US$11.9M. Across 3 filings, Opaleye Management Inc. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 931,000 shares valued at US$11.9M — a reduction of -325,228 shares quarter over quarter.. Notable position changes include a 489% increase in Q1 2026 (shares rose 98% over the following quarter), a 26% trim in Q2 2026 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 213.36K | $708.37K | New |
| Q1 2026 | 1.26M | $8.06M | Add |
| Q2 2026 | 931.00K | $11.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $34.62M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Logos Global Management LP 800.00K sh · $10.19M · Q2 2026
- Sanofi 244.08K sh · $3.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K sh · $769.02K · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held QTTB?
Opaleye Management Inc. has disclosed QTTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Opaleye Management Inc.'s current position in QTTB?
As of Q2 2026, Opaleye Management Inc. holds 931.00K shares of QTTB (Q32 Bio Inc), valued at $11.86M, representing 1.07% of its reported portfolio and ranking #27.
Has Opaleye Management Inc. been buying or selling QTTB?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. reduced its position in QTTB. The position peaked in Q2 2026 at 931.00K shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.